Twebwe, Uruganda rwa Farumasi rwa Changzhou nu ruganda rutanga amoko arenga 30 APIs nubwoko 120 bwuzuye. Kuva 1984, twemeje ubugenzuzi bwa FDA muri Amerika inshuro 16 kugeza ubu.
Dufite amashami 2 yose afite: Changzhou Wuxin na Nantong Chanyoo. Kandi Nantong Changzhou yemeje kandi ubugenzuzi bwa USFDA, EUGMP, PMDA na CFDA.
Nibyo, dushobora gusangira COA ninyandiko zijyanye no kwerekana abakiriya.
Niba umukiriya akeneye ibyangombwa, nka DMF, iraboneka nyuma yo kugerageza kubigenewe DMF ifunguye igice.
Ibi biterwa, kandi dushobora kuvuga dushingiye kumurongo nyirizina.
Ibi kandi bigomba kuvuga no kuganira bishingiye kumishinga itandukanye nubunini butandukanye.
Mubisanzwe, ingano ntarengwa ni 1kg.
Nibyo, mubisanzwe, dutanga 20g nkicyitegererezo cyubusa kugirango dushyigikire abakiriya.
Ku bwinshi, twashoboraga kohereza mu kirere; kandi niba hamwe na toni ubwinshi, twohereza mu nyanja.
Urashobora kohereza iperereza kuriyi imeri:shm@czpharma.com. Nyuma yimpande zombi zemejwe, dushobora kwemeza itegeko, hanyuma tugakomeza ubutaha.
Urashobora kutwoherereza imeri:shm@czpharma.com.
Cyangwa urashobora guhamagara kuri terefone: +86 519 88821493.
Tumaze gukorana nabakiriya benshi mpuzamahanga, nka: Novartis, Sanofi, GSK, Astrazeneca, Merck, Roche, Teva, Pfizer, Apotex, Sun Pharma. na ect.
Nantong Chanyoo nu ruganda rwacu rwose-uruganda rukora imiti rwa Changzhou.
Uruganda rwa farumasi rwa Changzhou nimwe muruganda rukora inganda za Shanghai Pharma. Itsinda.
Nibyo, dufite icyemezo cya GMP kuri Hydrochlorothiazide, Captopril na ect.
Ibicuruzwa byacu bitandukanye bifite ibyemezo bitandukanye, kandi mubisanzwe, dufite US DMF, US DMF, CEP, WC, PMDA, EUGMP, nka: Rosuvastatin.
Dufite amazina y'icyubahiro arenga 50, nka: Inganda 100 zikora imiti mu Bushinwa; Isosiyete ikora neza; Leta yashyizeho uruganda rukora imiti yibanze; Ubushinwa AAA urwego rwinguzanyo; Ikirangantego cyiza cya API cyohereza ibicuruzwa hanze; Ubushinwa HI-tekinoroji; Gukora amasezerano no kwizera isosiyete ikwiye; Uruganda rwerekana kwerekana ubuziranenge bwibiyobyabwenge nubunyangamugayo.
Muri 2018, tumaze kugera kuri USD88000. Kandi umuvuduko wubwiyongere bwumwaka ugera kuri 5.52%.
Nibyo, dufite ibigo 2 bya R&D bishinzwe iterambere rya APIs hamwe nibisobanuro byarangiye. Dushora 80% yibicuruzwa byacu muri R&D buri mwaka. Kugeza ubu, ubwoko bwacu bwa R&D burimo 31 rusange, 20 APIS, 9 ANDAs nibicuruzwa 18 byo gusuzuma.
Dufite amahugurwa 16 yubwoko bwose bwibicuruzwa.
Dutanga toni 1000+ kumwaka.
Dufite ubumenyi muri Cardiovascular, Anticancer, Antipyretic analgesic, Vitamine, Antibiotic na Health care medicine engineering, kandi nkuko byitwa: “Inzobere mu bijyanye na Cardio-Cerebrovascular”.